Ito, H., Ando, T., Arioka, Y., Saito, K., & Seishima, M. (2015). Inhibition of indoleamine 2,3-dioxygenase activity enhances the anti-tumour effects of a Toll-like receptor 7 agonist in an established cancer model. Immunology.
Stile di citazione ChicagoIto, Hiroyasu, Tatsuya Ando, Yuko Arioka, Kuniaki Saito, e Mitsuru Seishima. "Inhibition of Indoleamine 2,3-dioxygenase Activity Enhances the Anti-tumour Effects of a Toll-like Receptor 7 Agonist in an Established Cancer Model." Immunology 2015.
Citazione MLAIto, Hiroyasu, et al. "Inhibition of Indoleamine 2,3-dioxygenase Activity Enhances the Anti-tumour Effects of a Toll-like Receptor 7 Agonist in an Established Cancer Model." Immunology 2015.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.